Patents by Inventor Fernando Corrêa

Fernando Corrêa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230382983
    Abstract: The present invention provides antagonizing antibodies that bind to complement factor D (CFD), conjugates thereof, and methods of using same. The anti-CFD antibodies can be used therapeutically alone or in combination with other therapeutics to treat age related macular degeneration and other diseases.
    Type: Application
    Filed: February 6, 2023
    Publication date: November 30, 2023
    Inventors: Daniel Victor Perlroth, Wah Yuen To, Hong Liang, Rachel Marie DeVay Jacobson, Fernando Corrêa
  • Patent number: 11584790
    Abstract: The present invention provides antagonizing antibodies that bind to complement factor D (CFD), conjugates thereof, and methods of using same. The anti-CFD antibodies can be used therapeutically alone or in combination with other therapeutics to treat age related macular degeneration and other diseases.
    Type: Grant
    Filed: April 12, 2018
    Date of Patent: February 21, 2023
    Assignee: KODIAK SCIENCES INC.
    Inventors: Daniel Victor Perlroth, Wah Yuen To, Hong Liang, Rachel Marie DeVay Jacobson, Fernando Corrêa
  • Publication number: 20190270806
    Abstract: The present invention provides antagonizing antibodies that bind to IL-6, fusion proteins thereof with VEGF Trap, and conjugates of either thereof, and methods of using same. The anti-IL-6 antibodies can be used therapeutically alone or in combination with other therapeutics to diseases.
    Type: Application
    Filed: March 1, 2019
    Publication date: September 5, 2019
    Inventors: Rachel D. Jacobson, Fernando Corrêa, Hong Liang, D. Victor Perlroth
  • Publication number: 20180334496
    Abstract: The present invention provides antagonizing antibodies that bind to complement factor D (CFD), conjugates thereof, and methods of using same. The anti-CFD antibodies can be used therapeutically alone or in combination with other therapeutics to treat age related macular degeneration and other diseases.
    Type: Application
    Filed: April 12, 2018
    Publication date: November 22, 2018
    Inventors: D. Victor Perlroth, Wah Yuen To, Hong Liang, Rachel Marie DeVay Jacobson, Fernando Corrêa
  • Patent number: 5870700
    Abstract: A process for checking the Brazilian-Portuguese grammar of original text provided by a user. For each sentence, a token is generated to correspond to each of the words in the sentence. For each word in the sentence, an orthographic dictionary is searched to find possible variations in spelling, meaning and grammatical classification. Each token is expanded to include the variations in spelling, meaning and grammatical classification of its corresponding word. Each token is submitted to a heuristic process for excluding any variation which is incompatible with the token's juxtaposition within the sentence. Pre-analysis rules are applied to each token to identify and determine positionally correct alternatives for select pre-analysis errors in grammar based on the juxtaposition of each word within said sentence. An analysis tree, containing all of the tokens for the sentence and recording syntactic classification of the tokens and groups of tokens, is generated for the sentence.
    Type: Grant
    Filed: April 1, 1996
    Date of Patent: February 9, 1999
    Assignee: DTS Software, Inc.
    Inventor: Jose Fernando Correa Parra
  • Patent number: D650557
    Type: Grant
    Filed: February 28, 2011
    Date of Patent: December 20, 2011
    Assignee: Colombina S.A.
    Inventor: William Fernando Correa Gonzalez